Concepedia

Olatunji B. Alese

OB

Statistics

Publications

57

Citations

2.6K

H-Index

24

Active since

2006

Affiliations

Emory University(Current)

Winship Cancer Institute

Piedmont Cancer Institute

City of Hope

Michigan Cancer Research Consortium

Olatunji B. Alese is an author at Emory University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2006–2025

57

Publications

57

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

Richard D. Kim, Vincent Chung, Olatunji B. Alese et al. · JAMA Oncology · 2020 · 435 citations · Full text

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy

Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu et al. · Cancer · 2018 · 157 citations · Full text

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Mehmet Asım Bilen, Julie M. Shabto, Dylan J. Martini et al. · BMC Cancer · 2019 · 121 citations · Full text

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Arta M. Monjazeb, Anita Giobbie‐Hurder, Ana Lako et al. · Clinical Cancer Research · 2021 · 98 citations · Full text

1–5 of 57